摘要
原发性醛固酮增多症(primary aldosteronism,PA)是继发性高血压的首要病因,患病率呈逐年上升趋势,PA临床症状的不典型及多样化的并发症使其成为一项公共健康问题。全文以2016年更新的美国内分泌协会PA的临床实践指南及诊断治疗的国内专家共识为主要参考,对PA的规范化诊治进行解读。
Primary aldosteronism(PA)is the main cause of secondary hypertension and the prevalence is increasing year by year.The atypical clinical symptoms and diversified complications of PA make it become a public health problem.The full text uses the PA clinical practice guidelines of American endocrine society updated in 2016 and the domestic expert consensus on diagnosis and treatment as the main reference to interpret the standardized diagnosis and treatment of PA.
作者
赵菁
张进安
ZHAO Jing;ZHANG Jinan(Department of Endocrinology&Rheumatology of Zhoupu Hospital Affiliated to Shanghai University of Medicine&Health Sciences,Shanghai 201318,China)
出处
《上海医药》
CAS
2021年第8期3-6,共4页
Shanghai Medical & Pharmaceutical Journal
基金
国家自然科学基金资助项目(81873636)
上海市医学重点专科(ZK2019C09)
浦东新区卫健委联合攻关项目(PW2019D-12)
上海健康医学院甲状腺病临床研究中心项目(20MC20200002)。
